Table 1.
Participants’ demographic and clinical characteristics.
| Online group (n = 15) | Gym-based group (n = 15) | Total (n = 30) | p-values | |
|---|---|---|---|---|
| Age (years) | 54.1 ± 8.5 | 53.5 ± 6.6 | 53.8 ± 7.5 | 0.85 |
| Sex (male %) | 73 | 73 | 73 | |
| Body weight (kg) | 88.5 ± 18.1 | 87.5 ± 12.1 | 88.0 ± 15.1 | 0.87 |
| Height (cm) | 176.5 ± 7.6 | 174.6 ± 7.5 | 175.6 ± 7.5 | 0.49 |
| BMI (kg/m2) | 28.1 ± 3.8 | 28.7 ± 3.0 | 28.4 ± 3.4 | 0.67 |
| BSA | 2.0 ± 0.2 | 2.0 ± 0.2 | 2.0 ± 0.2 | 0.66 |
| LVEF (%) | 49.5 ± 11.5 | 51.1 ± 9.7 | 50.3 ± 10.5 | 0.67 |
| HR rest (bpm) | 73 ± 16 | 70 ± 18 | 72 ± 14 | 0.56 |
| SBP rest (mmHg) | 113.57 ± 18.23 | 121.74 ± 15.82 | 117 ± 14 | 0.13 |
| DBP rest (mmHg) | 72.43 ± 12.04 | 76.21 ± 18.61 | 74 ± 12 | 0.38 |
| Risk factors | ||||
| Hypertension, n (%) | 5 (33.3) | 4 (26.7) | 0.61 | |
| Diabetes mellitus, n (%) | 2 (13.3) | 3 (20) | 0.63 | |
| Dyslipidaemia, n (%) | 5 (33.3) | 7 (46.7) | 0.47 | |
| Smoking, n (%) | 8 (53.3) | 5 (33.3) | 0.27 | |
| Family history, n (%) | 4 (26.7) | 6 (40) | 0.44 | |
| Clinical | ||||
| Time after MI (months) | 3.5 | 3.2 | ||
| STEMI, n (%) | 12 (80) | 10 (66.7) | 0.41 | |
| Anterior, n (%) | 7 (46.7) | 6 (40) | 0.71 | |
| Inferior, n (%) | 5 (33.3) | 4 (26.7) | 0.69 | |
| NSTEMI, n (%) | 3 (20) | 5 (33.3) | 0.41 | |
| PCI, n (%) | 14 (93.3) | 13 (86.7) | 0.54 | |
| CABG, n (%) | 1 (6.7) | 2 (13.3) | 0.54 | |
| Medications | ||||
| Beta blockers, n (%) | 12 (80) | 13 (86.7) | 0.62 | |
| Antiplatelet, n (%) | 15 (100) | 15 (100) | 1.0 | |
| ACE inhibitors, n (%) | 13 (86.7) | 11 (73.3) | 0.36 | |
| Statin, n (%) | 14 (93.3) | 14 (93.3) | 1.00 | |
| Hypoglycaemic, n (%) | 2 (13.3) | 3 (20) | 0.62 | |
CABG, coronary artery bypass graft; DBP, diastolic blood pressure; PBF, percentage of body fat; STEMI, ST-elevation myocardial infarction; NSTEMI, non-ST elevation myocardial infarction; PCI, percutaneous coronary intervention; SBP, systolic blood pressure.